Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Volume:2 Issue:3 Number:90 ISSN#:2564-2537
Author Verified
RCT
ACE Report #551
Ace Report Cover Shoulder & Elbow

Platelet-rich plasma versus autologous whole blood for chronic lateral elbow epicondylitis


How to Cite

OrthoEvidence. Platelet-rich plasma versus autologous whole blood for chronic lateral elbow epicondylitis. ACE Report. 2013;2(3):90. Available from: https://myorthoevidence.com/AceReport/Report/551

Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A

Platelet-rich plasma versus autologous whole blood for the treatment of chronic lateral elbow epicondylitis: a randomized controlled clinical trial

Am J Sports Med; 2011; 39(10): 2130-2134

Contributing Authors: C Thanasas G Papadimitriou C Charalambidis I Paraskevopoulos A Papanikolaou

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

28 patients with chronic lateral epicondylitis were randomized to receive treatment with either a single injection of 3mL autologous blood or 3mL of platelet rich plasma (PRP) under ultrasound guidance. Patients who received PRP displayed greater VAS pain score improvement at all follow-up visits; however, significance was only observed at 6 week follow up. Additionally, it was found that there we...

To view the full report, start your 30-day free trial today

No credit card required

JOIN Forgot Password?

Not sure if you want to join OrthoEvidence?

Access this report without an Account.

Success, an email containing a link to access this report has been sent to your inbox.

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

LEARN MORE
For Reprints and Permissions, click here

Please Login or Join to leave comments.